Telogen Effluvium due to Recombinant Interferon α-2b

Authors:
  • CMC. Misciali
    C. Misciali
  • FBF. Bardazzi
    F. Bardazzi
  • PFP.A. Fanti
    P.A. Fanti
  • CVC. Varotti
    C. Varotti

Abstract
Five of 10 patients receiving long-term recombinant interferon alpha-2b therapy complained of considerable hair loss. The pull test and the trichogram showed a telogen count consistent with a telogen effluvium. In 2 patients the telogen count progressively improved despite continuing the treatment, whereas in 3 patients the trichogram continued to show an increased telogen count until interferon therapy was discontinued. Pohl-Pinkus hair constrictions were also present in 2 patients.